Catheter-directed Thrombolysis with the Endowave System in the Treatment of Acute Massive Pulmonary Embolism: A Retrospective Multicenter Case Series

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 3, 2008, Pages 372-376

  Chamsuddin, Abbas ^a   Nazzal, Lama ^a   Kang, Brandon ^a   Best, Irwin ^a   Peters, Gail ^a   Panah, Sepehr ^b   Martin, Louis ^a   Lewis, Curtis ^b   Zeinati, Chadi ^a   Ho, John W ^c   Venbrux, Anthony C ^d  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CATHETERIZATION; CLINICAL ARTICLE; DYSPNEA; ECHOGRAPHY; FEMALE; HUMAN; HYPOXIA; INFORMATION PROCESSING; LUNG EMBOLISM; LYSIS; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT CONTRAINDICATION; VASCULAR LESION;

ACUTE DISEASE; ADULT; AGED; CATHETERIZATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 39449119875     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.10.019     Document Type: Article

References (31)

1. Ryu J.H., Olson E.J., and Pellikka P.A. Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases. Mayo Clin Proc 73 (1998) 873-879
2. Ferris E.J., and George W. Holmes lecture: deep venous thrombosis and pulmonary embolism-correlative evaluation and therapeutic implications. AJR Am J Roentgenol 159 (1992) 1149-1155
3. Dalen J.E., and Alper J.S. Natural history of pulmonary embolism. Prog Cardiovasc Dis 17 (1975) 259-270
4. Dalen J.E. Pulmonary embolism: what have we learned since Virchow?. natural history, pathophysiology, and diagnosis. Chest 122 (2002) 1440-1456
5. Horlander K.T., Mannino D.M., and Leeper K.V. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 163 (2003) 1711-1717
6. Uflacker R. Interventional therapy for pulmonary embolism. J Vasc Interv Radiol 12 (2001) 147-164
7. Barrit D.W., and Jordan S.C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1 (1960) 1309
8. Hull R.D., Raskob G.E., Brant R.F., et al., American-Canadian Thrombosis Study Group. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. Arch Intern Med 160 (2000) 229-236
9. Eriksson B.I., Bauer K.A., Lassen M.R., Turpie A.G., and Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345 (2001) 1305-1310
10. Konstantinides S., Geibel A., Olschewski M., et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96 (1997) 882-888
11. Jerjes-Sanchez C., Ramirez-Rivera A., de Lourdes Garcia M., et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 2 (1995) 227-229
12. The urokinase pulmonary embolism trial: a national cooperative study. Circulation 47 2 suppl (1973) II1-II108
13. Konstantinides S., Geibel A., Heusel G., Heinrich F., Kasper W., and Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347 (2002) 1143-1150
14. Thabut G., Thabut D., Myers R.P., et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 40 (2002) 1660-1667
15. Meneveau N., Seronde M.F., Blonde M.C., et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 129 (2006) 1043-1050
16. Ullmann M., Hemmer W., and Hannekum A. The urgent pulmonary embolectomy: mechanical resuscitation in the operating theatre determines the outcome. Thorac Cardiovasc Surg 47 (1999) 5-8
17. Murphy K.D. Mechanical thrombectomy for DVT. Tech Vasc Interv Radiol 7 (2004) 79-85
18. Braaten J.V., Goss R.A., and Francis C.W. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 78 (1997) 1063-1068
19. Mahon B.R., Nesbit G.M., Barnwell S.L., et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 24 (2003) 534-538
20. White H.D., and Van de Werf F.J. Thrombolysis for acute myocardial infarction. Circulation 97 (1998) 1632-1646
21. Augustinos P., and Ouriel K. Invasive approaches to treatment of venous thromboembolism. Circulation 110 (2004) I27-I34
22. Kelly P., Carroll N., Grant C., Barrett C., and Kocka V. Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis. Heart Vessels 21 (2006) 124-126
23. McCotter C.J., Chiang K.S., and Fearrington E.L. Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: a review of 26 patients with and without contraindications to systemic thrombolytic therapy. Clin Cardiol 22 (1999) 661-664
24. Blinc A., Francis C.W., Trudnowski J.L., and Carstensen E.L. Characterization of ultrasound potentiated fibrinolysis in vitro. Blood 81 (1993) 2636-2643
25. Francis C.W., Blinc A., Lee S., and Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 21 (1995) 419-424
26. Trerotola S.O., McLennan G., Davidson D., et al. Preclinical in vivo testing of the Arrow-Trerotola percutaneous thrombolytic device for venous thrombosis. J Vasc Interv Radiol 12 (2001) 95-103
27. Sharafuddin M.J., Hicks M.E., Jenson M.L., Morris J.E., Drasler W.J., and Wilson G.J. Rheolytic thrombectomy with use of the AngioJet-F105 catheter: preclinical evaluation of safety. J Vasc Interv Radiol 8 (1997) 939-945
28. Gu X., Sharafuddin M.J., Titus J.L., et al. Acute and delayed outcomes of mechanical thrombectomy with use of the steerable Amplatz thrombectomy device in a model of subacute inferior vena cava thrombosis. J Vasc Interv Radiol 8 (1997) 947-956
29. Mewissen M.W., Seabrook G.R., Meissner M.H., Cynamon J., Labropoulos N., and Haughton S.H. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211 (1999) 39-49
30. Bjarnason H., Kruse J.R., Asinger D.A., et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 8 (1997) 405-418
31. Semba C.P., Bakal C.W., Calis K.A., et al. Alteplase as an alternative to urokinase: advisory panel on catheter-directed thrombolytic therapy. J Vasc Interv Radiol 11 (2000) 279-287